Clinical Trials Directory

Trials / Unknown

UnknownNCT03011827

Thromboelastometry in Liver Transplantation

Transfusion Prediction Model in Orthotopic Liver Transplantation Based on Thromboelastometry: Prospective Validation Study.

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
65 (estimated)
Sponsor
Hospital Clinic of Barcelona · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Thromboelastometry better assess coagulation than standard coagulation test in patients undergoing ortothopic liver transplantation. In a post-hoc analysis from a randomized study recently conducted by our group, presurgical values of MA10 Extem \< 35 mm are highly predictive of RBC administration , with no further improvement over MA10 Extem \>40 mm ; suggesting that MA10 Extem between 35-40 would be the optimal range to manage blood product administration. The aim of the study is to validate this result in a prospective cohort of patients submitted to ortothopic liver transplantation.

Conditions

Interventions

TypeNameDescription
OTHERFibrinogen and/or platelets administrationFibrinogen and/or platelets administration to maintain clot amplitude at 10 minutes of the thromboelastometry between 35-40 mm along liver transplant procedure

Timeline

Start date
2019-08-01
Primary completion
2022-09-01
Completion
2022-10-01
First posted
2017-01-05
Last updated
2019-08-07

Locations

2 sites across 1 country: Spain

Source: ClinicalTrials.gov record NCT03011827. Inclusion in this directory is not an endorsement.